These emerging medications , Tirzepatide , represent a remarkable advancement in managing type 2 diabetes and possibly related ailments . They are classified as GLP-1 receptor agonists , signifying they to mimic the endogenous GLP-1 peptide, boosting glucose secretion and suppressing food intake. Although Semaglutide every works relatively here sim